There was no significant difference in anti-gp210 antibodies between groups, but all PBC patients with positive anti-gp210 antibodies had 5- or 6-fold increased liver enzymes and 2- or 3-fold increased IgM levels, and they were more resistant to treatment. The gene discussed is NUP210; the disease is primary biliary cholangitis.